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Abstract: Functional near-infrared spectroscopy (fNIRS) is a noninvasive method for measuring in vivo
both hemodynamic and mitochondrial metabolic activities in brain cortical structures. Although the test–
retest reliability of the hemodynamic measures, such as reflected by oxygenated (HbO2), deoxygenated
(HHb) hemoglobin, and the tissue oxygenation index (TOI), has been previously reported to be good
to excellent, the reliability of the metabolic signal indexed by oxidized cytochrome-c-oxidase (oxCCO)
has not been reported. The present test–retest study compared the reliability of the metabolic and
hemodynamic signals in 10 healthy participants undergoing hypo- and hypercapnia challenges. The
primary reliability measure was the intraclass correlation coefficient (ICC). Results of both hypo- and
hypercapnia showed that the oxCCO signal (ICC = 0.876 / 0.757) had robust reliability comparable with
that of the HbO2 (ICC = 0.841 / 0.801), HHb (ICC = 0.804 / 0.571), and TOI (ICC = 0.574 / 0.614)
signals. These findings show that the oxCCO signal can be assessed by fNIRS with comparable reliability
to the hemodynamic measures. We discuss the results in light of current interest in a mitochondrial
metabolic marker derived from fNIRS.
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Abstract. Functional near-infrared spectroscopy (fNIRS) is a noninvasive method for measuring in vivo both
hemodynamic and mitochondrial metabolic activities in brain cortical structures. Although the test–retest reliabil-
ity of the hemodynamic measures, such as reflected by oxygenated (HbO2), deoxygenated (HHb) hemoglobin,
and the tissue oxygenation index (TOI), has been previously reported to be good to excellent, the reliability of the
metabolic signal indexed by oxidized cytochrome-c-oxidase (oxCCO) has not been reported. The present test–
retest study compared the reliability of the metabolic and hemodynamic signals in 10 healthy participants under-
going hypo- and hypercapnia challenges. The primary reliability measure was the intraclass correlation coef-
ficient (ICC). Results of both hypo- and hypercapnia showed that the oxCCO signal (ICC ¼ 0.876∕0.757) had
robust reliability comparable with that of the HbO2 (ICC ¼ 0.841∕0.801), HHb (ICC ¼ 0.804∕0.571), and TOI
(ICC ¼ 0.574∕0.614) signals. These findings show that the oxCCO signal can be assessed by fNIRS with com-
parable reliability to the hemodynamic measures. We discuss the results in light of current interest in a mito-
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1 Introduction
Functional near-infrared spectroscopy (fNIRS) is an optical
brain imaging method that has become a valuable neuroimaging
technique in research and clinical settings.1–4 The reliability of
fNIRS hemodynamic measures is good to excellent (for review
see Ref. 5). Test–retest performance has been examined in dif-
ferent conditions and age groups. Visual stimulation and finger-
tapping measured over the occipital6 and motor cortex7 in
healthy adults have been reported to have intraclass correlation
coefficients (ICC) of 0.84 and 0.80, respectively. Rhythmic
handgrip exercises measured over prefrontal lobe revealed sim-
ilar reliability in healthy adults (ICC ¼ 0.83) compared with
patients with moderate to severe traumatic brain injury (ICC ¼
0.70).8 Functional brain networks during resting-state investi-
gated using independent component analysis9 and graph met-
rics10 have been reported to exhibit fair (ICC ¼ 0.56) to good
(0.6 < ICC < 0.74) reliability, respectively. Excellent reliability
(ICC ¼ 0.89 to 0.94) has been shown in infants of ages 4 to 16
months during visual-auditory recordings.11 Studies of periph-
eral muscle in healthy adults during handgrip contraction found
ICC ¼ 0.86,12 and in patients with chronic heart failure during
leg muscle cycling, ICC ¼ 0.85 to 0.92.13
In addition to the hemodynamic measures based on the two
primary chromophores, i.e., oxygenated (HbO2) and deoxygen-
ated (HHb) hemoglobin (as assessed using wavelengths around
775 and 850 nm, respectively), fNIRS is also capable of monitor-
ing a third chromophore, which is the mitochondrial cytochrome-
c-oxidase (CCO), assessed using a wavelength around 810 nm
(Fig. 1) (for review see Ref. 14). The optical signature of the
CCO is predominantly the CuA center, which is the binuclear
copper site in soluble domains of CCO. fNIRS measures the
oxidation state of mitochondrial CCO, termed oxCCO signal,
which is an indicator of the CCO redox changes. CCO is the
terminal electron acceptor in the mitochondrial respiratory
chain and joint responsible for over 95% of the oxygen metabo-
lism in the synthesis of adenosine triphosphate,15 the main
source of cellular energy. The in vivo concentration of oxCCO
is ∼10% that of hemoglobin, making it harder to detect.16 Yet,
despite its small change in amplitude, the oxCCO signal is a
remarkably stable signal,14 and has a higher brain-specificity
compared with hemoglobin.17–19 While the hemoglobin mea-
sures, HbO2 and HHb, provide information on hemodynamic
circulation and intravascular oxygenation, oxCCO is an indica-
tor of cellular oxygen metabolism.20–23 Changes in oxCCO indi-
cate an alteration in the balance between oxygen delivery and
oxygen consumption.24 Hence, a more complete analysis of cer-
ebral health requires concurrent monitoring of all three chromo-
phores. Applications of this approach included assessment of
neonatal brain injury16 or traumatic brain injury,25,26 bedside
monitoring of cortical mitochondrial metabolic status in clinical
settings,22,23,27 or the assessment of cognitive tasks, such as
driving.28 These brain mitochondrial functions cannot be
assessed using other neuroimaging methods, such as functional
magnetic resonance imaging (fMRI).
Unlike the hemodynamic measures, the reliability of oxCCO
measurements has so far not been reported. Reasons for this
may be because it is harder to detect and requires special fNIRS
instrumentation14,16,18 that is currently commercially not available.
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In the present study, we therefore aimed to test–retest the
oxCCO signal and to provide a first estimate of its reliability in
a healthy population.
2 Materials and Methods
2.1 Participants
Ten physically and psychiatrically healthy adult volunteers [six
females, mean age ðSTDÞ ¼ 34 4.5 years] were recruited by
advertising and posted flyers. Exclusion criteria were any psy-
chiatric, or neurological disorder, unstable medical condition, or
pregnancy. All participants gave written informed consent. The
study was approved by the Institutional Review Board of the
New York State Psychiatry Institute and performed in accor-
dance with the Declaration of Helsinki.
2.2 Respiratory Challenges
Quantification of the oxCCO signal demands significant
changes in the arterial oxygen saturation to be reliably detected
in the cortex. Therefore, two respiratory challenges were chosen
as previously described29 to systemically manipulate cerebral
oxygenation via hypo- and hypercapnia, i.e., reduced and
increased carbon dioxide in the blood. For the test–retest design,
data from each participant were collected in two sessions at the
same time of the day separated by one week. In each session,
participants underwent both challenges.
Hypocapnia was induced by hyperventilation consisting of
five repetitions of alternate periods of rapidly breathing in and
out with constant respiratory volume (20 s) and normal breath-
ing (40 s) with a total duration of five minutes.
Hypercapnia was induced by breath-holding consisting of
five repetitions of alternate periods of breath hold (20 s) and
normal breathing (40 s) with a total duration of five minutes.
Participants were trained prior to recording to perform the
inspirational breath-hold volume of air similar to a normal
breath cycle to avoid inhaling larger volumes of air than the vol-
ume of a normal breath cycle.
Prior to and after each challenge, a resting-state of five
minutes was collected, during which participants were asked to
sit still with their eyes open to allow the hemodynamic cortical
system to normalize. The resting-state periods were not included
in the retest analysis.
2.3 Functional Near-Infrared Spectroscopy
Instrumentation
An NIRO 300 instrument (Hamamatsu Photonics) was used
to collect simultaneous measurements of the metabolic and
hemodynamic fNIRS signals. The instrument delivers four
wavelengths of light (775, 810, 850, and 910 nm, respectively,
Fig. 1) by four light sources (pulsed laser diodes) that are
detected by three closely placed detectors (photodiodes) (Fig. 2).
The concentration changes of oxCCO, HbO2, and HHb are mea-
sured by conventional differential spectroscopy with the use of a
modified Beer–Lambert law.30,31 In addition, the systemmeasures
the tissue oxygenation index (TOI) that is calculated based on
the principle of spatially resolved reflectance spectroscopy.30,32
Fig. 1 Chromophores absorption spectra. Spectra for the three chro-
mophores, HbO2 (as assessed using wavelengths around 775 nm),
HHb (around 850 nm), and oxCCO (around 810 nm), present in
human tissue that can be measured using fNIRS in the near-infrared
(NIR) range from 700 to 900 nm. The spectra are specified with
respect to their specific concentration in mM.
Fig. 2 (Left) NIRO 300 sensor. The light sources and detectors (∼10 × 10 mm2) were held in a light proof
holder and set at a distance of 4.5 cm. Concentration changes of oxCCO, HbO2, and HHb were mea-
sured by the middle photodiode, whereas TOI is measured by the use of all three. (Right) fNIRS setup.
Illustration of the probe positioning of the NIRO 300 (Hamamatsu Photonics). Areas of the dorsolateral
prefrontal cortex were identified using the Montreal Neurological Institute (MNI) space brain atlas con-
verted to the International 10–20 System.
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TOI can be approximated as the ratio of oxygenated to total tis-
sue hemoglobin. The oxCCO, HbO2, and HHb concentration
changes are measured by the middle photodiode, whereas
TOI is measured by the use of all three. The light sources
and detectors (∼10  10 mm2) were held in a light proof holder
and set at a distance of 4.5 cm. Both light sources and detectors
were fixed in a rubber probe to allow for direct skin contact. A
fiberoptic plate was used as the detector window, allowing light
to be conducted from the skin surface to the sensors without
distorting the spatial distribution. Placed under a flexible
head cap, two channels were positioned to cover parts of the
dorsolateral prefrontal cortex (i.e., Fp1 and Fp2 according to
the International 10–20 system33) (Fig. 2). Sampling rate was
set to 1 Hz. Data were detrended, zero-meaned, and band-
pass-filtered in the range 0.005 to 0.3 Hz, using a fifth-order
Butterworth filter, to remove physiological noise, using func-
tions of the HOMER2 processing package.34
Peripheral physiological measures were assessed using a
capnometer (LifeSense LS1-9R, Nonin Medical) by means of
the arterial tissue oxygen saturation (SpO2) and the partial
end-tidal carbon dioxide (PetCO2) of the exhaled air. Partici-
pants wore a nasal cannula through which tidal gases were
sampled at 1 Hz.
3 Data Analysis
All data analysis was performed using MATLAB® (Release
2017b, MathWorks, Massachusetts).
fNIRS data from both channels were averaged. Changes of
the concentration of ΔoxCCO, ΔTOI, ΔHbO2, and ΔHHb were
used as indicators of metabolic and hemodynamic activities.1,7,11
The five hypo- and hypercapnia intervals were block-averaged
and relative concentration changes were computed from the end
of the rest period (i.e., time-locked two seconds before onset of
hypo-/hypercapnia) to the end of the challenge period (i.e., time-
locked two seconds after offset of hypo-/hypercapnia). The sub-
ject-specific signal changes were then used for the reliability
analysis.
Fig. 3 Measured signals. Experimentally measured peripheral physiological signals (PetCO2, SpO2) and
fNIRS signals (oxCCO, TOI, HbO2, and HHb, baseline corrected) are indicated by black lines. Gray
patches indicate the hypo- and hypercapnia intervals (20 s) alternating with rest periods of normal breath-
ing (40 s). Data are shown for an example participant.
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3.1 Reliability
As primary measure of test–retest reliability, the ICC was
applied using the following previous recommendations:5
• ICCwas computed as type “3–1” according to the Shrout and
Fleiss convention,35 i.e., a two-way mixed single measures.
• The two-way mixed model was chosen based on the
assumption that the results may not be generalized to
fNIRS instruments other than the NIRO 300 (since cur-
rently commercially not available). The type of single
measures was chosen because only the NIRO 300 instru-
ment was used.
• ICC was calculated with confidence intervals based on
an alpha level of significance p < 0.05. The correspond-
ing p-value of a hypothesis test with the null hypothesis
ICC ¼ 0 was reported.
• Following the guidelines for interpretation by Cicchetti,36
the ranges of ICC < 0.40, ICC 0.40 to 0.59, ICC 0.60 to
0.74, and ICC > 0.75, were considered to reflect poor, fair,
good, and excellent test–retest reliability, respectively.
3.2 Agreement
As measure of agreement, Bland–Altman plots37–39 were
applied, which are based on the analysis of the differences
between two measurements. Agreement quantifies how close
two measurements made on the same subject are and is given
in unit scale as the measurements themselves.40 The correspond-
ing estimates of agreement, i.e., mean difference, with lower and
upper 95% limits of agreement (LoA), help in interpretation of
the ICC41 in that they uncover trends or consistent bias between
measurement sessions.
3.3 Repeatability
Bland–Altman plots can also be used to assess the repeatability
of a measure. The plot is then used to check whether the vari-
ability or precision is related to the size of the characteristic sig-
nal being measured. Optimally, for repeated measurements of
the same instrument, the mean difference should be zero. There-
fore, the coefficient of repeatability (CR) can be derived as two
times the standard deviation of the differences between the two
measurements.37
As the CR is a measure in the same unit scale as the mea-
surements themselves, the coefficient of variation (CV) was cal-
culated as an additional measure of dispersion expressed in
percentage (%). The CV is defined as the ratio of the standard
deviation to the absolute value of the mean.
4 Results
The experimentally measured signals from an example partici-
pant are shown in Fig. 3. The peripheral physiological data
Fig. 4 Signal changes. Block-averaged signal changes across all participants of the peripheral physio-
logical measures (ΔPetCO2, ΔSpO2) and fNIRS data (ΔoxCCO, ΔTOI, ΔHbO2, and ΔHHb) for hypo-
capnia (black) and hypercapnia (gray). Error bars indicate the standard error of the mean (SEM). There
were no significant differences “between sessions” as assessed using ANOVA.
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PetCO2 and SpO2, as well as the fNIRS data oxCCO, TOI,
HbO2, and HHb, are illustrated over the time course of the
five hypo- and hypercapnia intervals (gray patches). All signals
showed a relative change in response to hypo- and hypercapnia
and a return close to baseline values after each challenge.
The block-averaged signal changes “across sessions”
reflected typical responses to hypo- and hypercapnia (Fig. 4).
Both the time courses as well as the relative magnitudes of the
oxCCO, ΔTOI, ΔHbO2, and ΔHHb signals obtained during the
respiratory challenges are in agreement with previous work.19,28
In response to hypocapnia, we observed a decrease in ΔPetCO2
and an increase in ΔSpO2, whereas the fNIRS data showed a
decrease in ΔoxCCO, ΔTOI, ΔHbO2, and an increase in
ΔHHb. The opposite pattern was observed in response to hyper-
capnia, an increase in ΔPetCO2, a decrease in ΔSpO2, an
increase in ΔoxCCO, ΔTOI, ΔHbO2, and a decrease in ΔHHb.
Importantly, there were no significant differences between
sessions for any of the signals as assessed using ANOVA
(one-way main effects of “session”: hypocapnia ΔPetCO2 F ¼
1.102, p ¼ 0.307; hypercapnia ΔPetCO2 F ¼ 0.798, p ¼
0.383; hypocapnia ΔSpO2 F ¼ 2.037, p ¼ 0.171; hypercapnia
ΔSpO2 F ¼ 0.466, p ¼ 0.503; hypocapnia ΔoxCCO F ¼
0.418, p ¼ 0.526; hypercapnia ΔoxCCO F ¼ 0.001, p ¼
0.967; hypocapnia ΔTOI F ¼ 1.346, p ¼ 0.261; hypercapnia
ΔTOI F ¼ 0.018, p ¼ 0.893; hypocapnia ΔHbO2 F ¼ 3.366,
p ¼ 0.083; hypercapnia ΔHbO2 F ¼ 1.367, p ¼ 0.257; hypo-
capnia ΔHHb F ¼ 0.657, p ¼ 0.428; hypercapnia ΔHHb F ¼
1.036, p ¼ 0.332). The nonsignificance between sessions is
considered to be an important aspect for ICC selection as it helps
in determining the selection between one- or two-way models.5
The subject-specific signal changes were then used to esti-
mate the reliability between sessions (Figs. 5 and 6, Table 1).
Fig. 5 Reliability, agreement, and repeatability PetCO2, SpO2, and oxCCO. (a) ICCs (CI) and (b) scat-
ter plots illustrating the reliability between sessions. (c) Bland–Altman plots illustrating the agreement and
repeatability between sessions as assessed by the mean differences. Data are shown for both hypo-
capnia (black) and hypercapnia (gray). See Table 1 for statistics.
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ICCs demonstrated good to excellent reliability for the periph-
eral measures ΔPetCO2 (hypo-/hypercapnia ICC ¼ 0.518∕745)
and ΔSpO2 (ICC ¼ 0.871∕937). The NIRS data exhibited
excellent reliability in all signals ΔoxCCO (ICC ¼
0.933∕876), ΔTOI (ICC ¼ 0.735∕922), ΔHbO2 (ICC ¼ 0.930∕
905), and ΔHHb (ICC ¼ 0.916∕579) as illustrated in the scat-
ter plots.
In accordance, Bland–Altman plots demonstrated good
agreement for all signals without significant differences in the
mean differences as assessed using ANOVA. The evenly scat-
tered measurement points without trends suggested that there
was no consistent bias between sessions (Figs. 5 and 6). The
mean differences were smaller for the oxCCO signal compared
with the hemodynamic signals (Table 1) indicating that the met-
abolic measurements separated by a week were closer.
Repeatability refers to the variation in a measure under
identical conditions over which the underlying signal can be
considered to be constant.40 Under such conditions, variability
may then be ascribed to the measurement process itself. The CR
is a precision measure representing the unit scale value below
which the absolute difference between two repeated measure-
ments may be expected to lie with a probability of 95%. In our
case, we observed a smaller CR for the oxCCO signal (CR ¼
0.248∕0.157) compared with the hemodynamic signals
(Table 1) most likely because its in vivo concentration is ∼10%
that of hemoglobin. Therefore, the CRs of the metabolic and the
hemodynamic signals may not be directly comparable.
The CV as another measure of dispersion, however, is
expressed as a percentage, thus allowing for a direct comparison
between the metabolic and the hemodynamic signals. The CV
also showed a relatively small value for the oxCCO signal
(CV ¼ 4.432%∕3.694%) compared with the hemodynamic sig-
nals (Table 1) suggesting that the degree of variation between
sessions was smaller. Notably, the CVof the peripheral measures
Fig. 6 Reliability, agreement, and repeatability TOI, HbO2, and HHb. (a) ICCs (CI) and (b) scatter plots
illustrating the reliability between sessions. (c) Bland–Altman plots illustrating the agreement and repeat-
ability between sessions as assessed by the mean differences. Data are shown for both hypocapnia
(black) and hypercapnia (gray). See Table 1 for statistics.
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(PetCO2, SpO2) cannot be compared with those of the fNIRS
signals because of the different units.
5 Discussion
Cortical CCO measurements derived from fNIRS can yield cru-
cial information about cerebral mitochondrial metabolism. As
its first demonstration in 1977,42 recent developments in instru-
mentation and analytical methods used to resolve the oxCCO
signal16,43,44 have led to several clinical applications of the meas-
urement as indicated by a substantial literature regarding mea-
sures of CCO in humans (for review see Ref. 14). With the
potential ability to use the oxCCO signal as a marker of mito-
chondrial health, this signal is important for our understanding
of the human brain in health and disease.
The present test–retest study showed evidence for the reli-
ability of the mitochondrial metabolic signal and compared it
with those of the hemodynamic fNIRS signals in human brain.
Reliability of the hemodynamic measurements has been previ-
ously shown to be excellent in healthy adults (ICC ¼ 0.80 to
0.84),6–8 in line with our results (ICC ¼ 0.707 to 0.841).
Reliability of the metabolic oxCCO signal, in contrast, has not
been published previously and we found it to be excellent as
well (ICC ¼ 0.827 to 0.913) (Figs. 5 and 6, Table 1). Together,
these findings suggest that the oxCCO signal can be reliably
measured under conditions of respiratory challenges to be
implemented effortlessly in both research and clinical settings.
Reliability depends on several aspects that should be kept in
mind when interpreting our results. Regarding instrumentation,
the present study utilized an NIRO 300 instrument (Hamamatsu
Photonics), an early-generation instrument built ∼20 years ago.
The NIRO 300 instrument has overall been shown to produce
valid measurements of the oxCCO signal.20,45–53 However, it
belongs to those early-generation instruments that used only
four discrete wavelengths (775, 810, 850, and 910 nm, respec-
tively) to assess both the metabolic and hemodynamic signals.
These wavelengths are in relatively good agreement with the
optimal wavelengths reported for CCO measures.43 Nonethe-
less, this technology has been superseded by systems using
broadband spectroscopy covering a near-infrared wavelength
resolution from ∼780 to 900 nm that is thought to obtain a
more robust oxCCO signal.16,24,43,54 There are also novel signal
algorithms based on diffusion approximation, which have been
suggested as an alternative to the modified Beer–Lambert’s law
used in the present work for the deconvolution of oxCCO.54,55
Such algorithms are thought to avoid the possibility of cross talk
between the hemodynamic and metabolic changes that might
occur when using the MBLL algorithm.56,57 It is thus possible
that some of the drawbacks of the NIRO 300 instrumentation,
such as low wavelength resolution and possible cross talk,
might have affected the reliability of the present data. The exact
evaluation of the corresponding instrumental behavior would,
however, go beyond the scope of the present work. Using
Table 1 Reliability, agreement, and repeatability. ICCs and Bland–Altman measures, i.e., the MD with lower and upper LoA, the CR and the CV,
between sessions for both the hypo- and hypercapnia challenge. See Figs. 5 and 6 for illustration.
ΔPetCO2 ΔSpO2 ΔoxCCO ΔTOI ΔHbO2 ΔHHb
Hypocapnia Reliability ICC 0.793 0.667 0.827 0.574 0.841 0.804
Upper 95% CI 0.944 0.905 0.954 0.874 0.958 0.948
Lower 95% CI 0.366 0.109 0.449 −0.043 0.483 0.392
p-value 0.002 0.012 0.001 0.032 0.001 0.001
Agreement MD −3.860 0.015 0.062 −0.709 −0.366 0.127
Upper 95% LoA −0.633 0.053 0.310 1.762 0.128 0.556
Lower 95% LoA −7.088 −0.023 −0.185 −3.180 −0.860 −0.302
Repeatability CR 3.228 0.038 0.248 2.471 0.494 0.429
CV % 0.814 3.455 4.432 1.033 2.003 1.320
Hypercapnia Reliability ICC 0.687 0.833 0.913 0.502 0.805 0.707
Upper 95% CI 0.912 0.956 0.978 0.848 0.948 0.918
Lower 95% CI 0.146 0.463 0.690 −0.143 0.393 0.182
p-value 0.010 0.001 0.000 0.058 0.001 0.008
Agreement MD 0.597 0.008 −0.004 −0.065 0.275 −0.131
Upper 95% LoA 2.910 0.036 0.154 2.042 0.918 0.301
Lower 95% LoA −1.717 −0.021 −0.161 −2.173 −0.369 −0.562
Repeatability CR 2.314 0.029 0.157 2.108 0.644 0.431
CV % 0.648 22.016 3.694 5.708 11.144 2.658
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technology reliability of the metabolic signal may even improve.
This consideration has been accounted for in the ICC calculation
(i.e., by choosing the corresponding type two-way mixed model
with single measures).
Regarding timing, the test–retest data were collected in two
sessions separated by one week. It may be assumed that, within
this time period, the intervening respiratory challenges did not
change the ability to induce hypo- and hypercapnia. Participants
were further asked to maintain their breathing patterns between
sessions such as the strength or depth of breath during hyper-
ventilation. Thus, test–retest reliability should have not been
compromised by timing. This assumption was supported by
the good reliability observed for the respiratory parameters
(PetCO2 ICC ¼ 0.793∕0.687, SpO2 ICC ¼ 0.667∕0.833)
reflecting consistency of the administered respiratory challenges
(Figs. 5 and 6, Table 1). Longer time spans, in contrast, such as
a year or more, may affect reliability or circumstances where
individuals experience changes in pulmonary, metabolic, or vas-
cular systems, reflecting a change in signal and its measurement.
Regarding probe positioning, the test–retest data were col-
lected from the same cortical areas, repositioned by the same
experimenter. The probe itself, however, consisted of only a
small number of channels. Nonetheless, this aspect was consid-
ered of minor relevance for the purpose of test–retesting as the
spatial distribution of oxCCO changes in human brain requires
further investigation before being quantified.44,58 In other words,
we expected to deal with global (nonlocalized) changes across
the whole prefrontal cortex suggested to be unchanged between
sessions. Considering cerebral pathological changes, in contrast,
would unlikely be expected to have a uniform distribution across
the brain, such as in the case of known brain disease or brain
injury and may then require regional (localized) measures of
oxCCO. Signal alterations in such cases may be smaller than
those tested in this study and may require measurements of
greater reliability.
6 Conclusion
Taken together, we found robust reliability of both the metabolic
oxCCO signal and the hemodynamic signals derived from
fNIRS in the human brain. These findings suggest that the
oxCCO signal can be reliably measured under conditions of res-
piratory challenges to be implemented effortlessly in both
research and clinical settings.
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